Susceptible bacteria increased with limited usage of antibiotics: Data with emphasis on defined daily doses

Pediatrics International

Volumn 51, Issue 5, 2009, Pages 696-699

  Takeuchi, Hajime ^a  

^a Mimihara General Hospital   (Japan)

Author keywords

Amoxicillin; Defined daily doses; Haemophilus influenzae; Limited usage of antibiotics; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFACLOR; CEFDINIR; CEFIXIME; CLARITHROMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG SENSITIZATION; DRUG USE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPUTUM ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 70349589227     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02847.x     Document Type: Article

References (25)

1. Jacobs MR, Felmingham D, Appelbaum PC et al. The Alexander project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infections to commonly used antimicrobial agents. J. Antimicrob. Chemother. 2003 52 : 229 246.
2. Chiba N, Kobayashi R, Hasegawa K et al. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotypes of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. J. Antimicrob. Chemother. 2005 56 : 756 760.
3. Ubukata K, Chiba N, Hasegawa K et al. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob. Agents Chemother. 2004 48 : 1488 1494.
4. Hasegawa K, Chiba N, Kobayashi R et al. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 2004 48 : 1509 1514.
5. Kusakari A, Takeuchi H, Haga K et al. Research on antibiotic usage for upper respiratory tract infections in pediatric outpatients in Japan. J. Ambul. Gen. Pediatr. 2004 7 : 122 127.
6. Kusakari A, Takeuchi H, Nishimura T et al. Guidelines for the judicious use of antibiotics for upper respiratory infections and other related disorders in children. J. Ambul. Gen. Pediatr. 2005 8 : 146 173 (in Japanese).
7. Kusakari A, Takeuchi H, Nishimura T et al. Good Practice Guide Accessed 24 October 2008. Available from URL: http://www004.upp.so-net.ne.jp/ped-GL/ antibiotics-guidlines.pdf (in English).
8. ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 2005 Accessed 24 October 2008. Available from URL: http://www.whocc.no/atcddd/
9. Appelbaum PC, Bhamjee A, Scragg JN et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977 12 : 995 997.
10. Hasegawa K, Chiba N, Kobayashi R et al. Rapidly increasing prevalence of beta-lactamaze-nonproducing, Ampicillin-resistant Haemophilus influenzae Type b in patients with meningitis. Antimicrob Agents Chemother 2004 48 : 1509 1514.
11. Cars O, Mölstad S, Melander A. Variation in antibiotics use in the European Union. Lancet 2001 357 : 1851 1853.
12. Goossens H, Ferech M, Vander R et al. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005 365 : 579 587.
13. Bronzwaer SLAM, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 2002 8 : 278 282.
14. Bronzwaer SLAM, Buchholz U, Kool JL. International surveillance of antimicrobial resistance in Europe: Now we also need to monitor antibiotic use. Eurosurveillance 2001 6 : 1 2.
15. Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA 1996 275 : 175.
16. Kristinson KG. EARSS in Iceland. Annu. Rep. EARSS 2000 73 7.
17. Seppälä H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 1997 337 : 441 446.
18. Melander E, Hansson HB, Mölstad S et al. Limited spread of penicillin-nonsusceptible pneumococci, Skåne county, Sweden. Emerg. Infect. Dis. 2004 10 : 1082 1087.
19. Mölstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA). Scand. J. Infect. Dis. 1999 31 : 191 195.
20. Vardhan MS, Allen KD, Bennett E. Antibiotic prescribing and penicillin-resistant pneumococci in a Merseyside health district. J. Infect. 2003 46 : 30 4.
21. Morley DC. A simple method of testing the sensitivity of wound bacteria to penicillin and sulphathiazole by the use of impregnated blotting paper discs. J. Pathol. Bacteriol. 1945 57 : 379 385.
22. Jorgensen JH, Ferraro MJ, Craing WA et al. Performance standards for antimicrobial disk susceptibility tests-sixth edition; approved standard. NCCLS, Wayne, USA, 1998; 17.
23. Nasrin D, Collignon PJ, Roberts L et al. Effect of beta-lactam antibiotic use in children on pneumococcal resistance to penicillin: Prospective cohort study. BMJ 2002 324 : 28 30.
24. WHO. Global programme for vaccines and immunization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol. Rec. 1998 10 : 64 8.
25. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 2000 13 : 302 317.